Ameriprise’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-7,182
| Closed | -$696K | – | 3799 |
|
2019
Q3 | $696K | Sell |
7,182
-2,057
| -22% | -$199K | ﹤0.01% | 3164 |
|
2019
Q2 | $947K | Sell |
9,239
-20,443
| -69% | -$2.1M | ﹤0.01% | 3085 |
|
2019
Q1 | $3.38M | Sell |
29,682
-120,296
| -80% | -$13.7M | ﹤0.01% | 2476 |
|
2018
Q4 | $5.87M | Buy |
149,978
+38,544
| +35% | +$1.51M | ﹤0.01% | 2018 |
|
2018
Q3 | $6.08M | Sell |
111,434
-20,483
| -16% | -$1.12M | ﹤0.01% | 2214 |
|
2018
Q2 | $10.9M | Sell |
131,917
-36,111
| -21% | -$2.99M | ﹤0.01% | 1663 |
|
2018
Q1 | $11.2M | Sell |
168,028
-3,796
| -2% | -$253K | 0.01% | 1575 |
|
2017
Q4 | $8.84M | Sell |
171,824
-35,536
| -17% | -$1.83M | ﹤0.01% | 1703 |
|
2017
Q3 | $18.5M | Buy |
207,360
+11,785
| +6% | +$1.05M | 0.01% | 1099 |
|
2017
Q2 | $11.7M | Sell |
195,575
-43,610
| -18% | -$2.61M | 0.01% | 1421 |
|
2017
Q1 | $12.8M | Buy |
239,185
+445
| +0.2% | +$23.7K | 0.01% | 1348 |
|
2016
Q4 | $11.9M | Buy |
238,740
+109,113
| +84% | +$5.45M | 0.01% | 1390 |
|
2016
Q3 | $7.79M | Buy |
129,627
+32,023
| +33% | +$1.92M | ﹤0.01% | 1648 |
|
2016
Q2 | $4.99M | Sell |
97,604
-136,956
| -58% | -$7M | ﹤0.01% | 1942 |
|
2016
Q1 | $6.92M | Buy |
234,560
+59,028
| +34% | +$1.74M | ﹤0.01% | 1721 |
|
2015
Q4 | $7.95M | Buy |
175,532
+93,255
| +113% | +$4.22M | ﹤0.01% | 1631 |
|
2015
Q3 | $3.44M | Buy |
82,277
+30,455
| +59% | +$1.27M | ﹤0.01% | 2268 |
|
2015
Q2 | $3.13M | Buy |
51,822
+6,734
| +15% | +$406K | ﹤0.01% | 2449 |
|
2015
Q1 | $3.49M | Buy |
+45,088
| New | +$3.49M | ﹤0.01% | 2290 |
|